Dr. Paul Stephen Fitzmorris, MD

Dr. Fitzmorris practices at The Baton Rouge Clinic, AMC in Baton Rouge, Louisiana.

Dr. Fitzmorris' NPI, 1841633872, was assigned on April 9, 2013. Dr. Fitzmorris graduated from Louisiana State University School of Medicine in New Orleans in 2013. Dr. Fitzmorris holds Louisiana license 311552.

Dr. Fitzmorris' primary practice is The Baton Rouge Clinic, AMC, at 7373 Perkins Road, Baton Rouge, LA 70808.

Dr. Fitzmorris' primary practice is The Baton Rouge Clinic, AMC in Baton Rouge, Louisiana. Dr. Fitzmorris is also affiliated with Our Lady of the Lake Regional Medical Center. The medical group on file is The Baton Rouge Clinic. Dmand AI also links Dr. Fitzmorris to 1 more hospital and 1 group practice or clinic, each named with a free account. Dr. Fitzmorris' employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fitzmorris practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Fitzmorris' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Fitzmorris is licensed in Louisiana.

CMS data shows 904 Medicare services from Dr. Fitzmorris across 19 procedure codes in 2024, for 258 Medicare patients. Medicare paid $53,079 for them.

CMS counts 258 Medicare patients who saw Dr. Fitzmorris in 2024. The largest group is 65 to 74, with 140 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fitzmorris' median patient age at 62, with 55% women.

In 2024, Dr. Fitzmorris wrote 1,753 Medicare Part D claims for 522 patients. 81% of them were for generic drugs. CMS names the drug for 1,545 of them, across 22 drugs with 11 or more claims each, at $199,920 in total drug cost. In 2023, CMS named 1,687 claims across 26 drugs.

Dr. Fitzmorris accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fitzmorris as offering telehealth. CMS counts 72 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Fitzmorris, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Dr. Fitzmorris, published from 2015 to 2018. 2015 was the busiest year, with 2. The most frequent topics are Tertiary Care Centers. Dr. Fitzmorris' most frequent co-authors are Donny Debajyoti Kakati, MD, Talha Aziz Malik, MD and Omar I. Massoud, MD.

CMS Open Payments shows 151 general payments to Dr. Fitzmorris from 24 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 83% of the total. Janssen Pharmaceuticals, Inc paid the most, $738.

Dr. Fitzmorris graduated from Louisiana State University School of Medicine in New Orleans in 2013.